GLP-1 Before and After: Realistic Expectations Week by Week

GLP-1 before-and-afters on social media tend to feature the most dramatic results — 80 pound losses, jawline transformations, clothes that no longer fit. These results are real. They also represent the high end of a distribution, not the median.

Here's what actually happens, week by week, for the typical patient who follows the protocol correctly.

Week 1-2: The Appetite Shift Begins

Most patients don't lose significant weight in the first two weeks. What they notice is the food noise going quiet.

"Food noise" — the persistent background preoccupation with eating, snacking, hunger, and what comes next — is something most people don't even realize they have until GLP-1 makes it stop. It just... gets quieter. Sometimes dramatically so.

What else happens in week 1-2: - Reduced appetite, sometimes dramatically so - Possible nausea (especially on tirzepatide; milder on starting semaglutide doses) - Feeling full faster than expected - Possible fatigue as your body adjusts to eating less - Some patients: mild headache, constipation, or loose stools

Scale movement: Many patients see 1-3 pounds in week 1, mostly water weight from reduced carbohydrate intake. Don't read too much into this number.

Week 3-4: First Real Results

By week 3-4, most patients start to see real weight loss. The appetite suppression has stabilized and most nausea has improved. Body weight typically shows 4-8 pounds down from baseline at this point for patients following the protocol.

What's happening physiologically: insulin sensitivity is already improving, even before visible body composition changes. Glucose levels are more stable throughout the day, which many patients notice as more consistent energy.

What to do now: Start resistance training if you haven't. The metabolic window of GLP-1 treatment is most protective of muscle mass when combined with strength training. The earlier you start, the better the body composition outcome.

See our [guide to protecting muscle on GLP-1](/blog/glp1-muscle-loss-prevention).

Month 1: The First Milestone (4-6% Body Weight)

At 4 weeks, patients in clinical trials averaged 4-6% body weight reduction. For a 200-pound person, that's 8-12 pounds.

This is when clothes start fitting differently. It's when people around you might start to notice. It's also when motivation tends to peak — the medication is clearly working, results are visible, adherence is high.

Common experiences at month 1: - Better sleep (often reported unprompted) - Increased energy - Reduced cravings, especially for high-sugar foods - Some patients: a brief plateau as the body adjusts to new setpoint

Month 2: The Compound Effect

Month 2 is where the appetite suppression compounds. You've adapted to eating less, your metabolic rate is adjusting, and the medication continues to push the setpoint down.

Average weight loss by week 8-12: 8-12% of starting body weight.

For a 200-pound person, that's 16-24 pounds. Body composition changes are now visible in photos. Energy is often the best it's been in years.

What to watch for: - Adequate protein intake becomes more important as total calories fall - Constipation can become an issue — hydration and fiber matter - Some patients need to work harder to eat enough (the appetite suppression can be too effective for some) - Your physician should be reviewing progress — dose titration may be appropriate

Month 3: First Major Checkpoint

At 12 weeks, clinical trials show average weight loss of 10-15% of starting body weight on semaglutide, and 15-20%+ on tirzepatide for high responders.

This is when the before-and-after photos start to get dramatic.

But month 3 is also when some patients hit their first meaningful plateau. The body's set-point defense mechanisms start pushing back against sustained caloric deficit. This is normal, not failure.

How to break through a month 3 plateau: - Reassess protein intake (aim for 1g per pound bodyweight) - Add or increase strength training - Check that you're not "eating around" the medication (high-calorie liquid calories, etc.) - Discuss dose adjustment with your physician

Month 4-5: The Maintenance Phase Emerges

For many patients, weight loss slows in months 4-5 as the new setpoint stabilizes. The medication is still working — it's maintaining the loss while allowing the body to adjust.

This is physiologically appropriate and expected. The STEP trials showed a characteristic flattening of the weight loss curve around month 4-5 before potentially resuming with dose increases.

Focus in this phase: Body recomposition. If you're training, you may be building muscle while losing fat — meaning the scale moves less but your body composition continues to improve. Measure progress with photos, measurements, and how you feel, not just scale weight.

Month 6: Clinical Milestone

At 6 months, the average weight loss in the STEP 1 trial was approximately 12-14% of body weight for semaglutide at maximum dose. Tirzepatide (SURMOUNT-1) showed 15-20%+ at maximum dose.

For a 220-pound person starting at maximum adherence: that's 26-44 pounds.

The before-and-afters at this point are real. Metabolic markers (HbA1c, fasting glucose, triglycerides, blood pressure) have typically improved substantially. Liver fat is reduced. Inflammatory markers are down.

What The Average Actually Looks Like

Setting realistic expectations:

| Timeframe | Average Weight Loss | What You'll Notice | |-----------|--------------------|--------------------| | Week 1-2 | 1-3 lbs (mostly water) | Food noise quieting | | Month 1 | 4-6% body weight | Clothes fitting differently | | Month 3 | 10-15% body weight | Visible transformation | | Month 6 | 12-20% body weight | Dramatic before/after |

These are averages. Some patients lose faster, some slower. Non-responders (rare — under 5-10% of patients) exist and should be evaluated for adherence, dose, and metabolic factors.

Why Some People Don't Get Dramatic Results

If you're 3+ months in and not seeing expected results:

1. Caloric compensation: Some patients unconsciously eat more calorie-dense foods when appetite decreases. Track calories honestly for a week.

1. Dose inadequacy: Starting doses are designed to minimize side effects, not maximize results. Discuss whether titration is appropriate.

1. Medication quality: Compounded medications vary in potency between pharmacies. If you changed pharmacies and results changed, this matters.

1. Metabolic factors: Thyroid dysfunction, cortisol dysregulation, and other endocrine issues can blunt response. A complete hormonal panel is worth doing if results are poor.

1. Lifestyle factors: GLP-1 is most effective when combined with adequate protein and resistance training. It's not fully independent of these factors.

[Start your GLP-1 protocol at Marrow](/start) — physician consultation, labs, and prescription included.